Streetbeat News

Earnings

LOWLF

Lowell Farms Inc (OTCQB:LOWLF), a California-based cannabis company, reported a 35% decrease in annual revenue for 2023, totaling $28.3 million, and a 19% decrease in Q4 revenue to $7.5 million. The company experienced a net loss of $37.3 million for the year and $13.1 million for Q4. Despite these challenges, Lowell Farms is optimistic about its restructuring and strategic realignments aimed at improving its operational framework and financial health.

Portfolio Pulse from Patricio Liddle

March 28, 2024 | 3:26 pm

SSKN

Strata Skin Sciences shares are trading lower following the announcement of their Q4 financial results, which were below market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:24 pm

TAYD

Taylor Devices (TAYD) shares are trading higher following the announcement of improved Q3 financial results compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:22 pm

TOI

The Oncology Institute's shares dropped following the announcement of disappointing Q4 GAAP EPS results, which were below market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:20 pm

UGRO

Urban-Gro's stock price is trading lower following the announcement of disappointing Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:19 pm

IMCC

IM Cannabis Corp. reported a 10% decrease in annual revenue for 2023, attributing it to negative currency fluctuations and the Israel-Hamas war's impact on operations. Despite a 68% drop in Q4 gross profit, the company sees growth opportunities in Germany following new cannabis legislation. Financial highlights include a 7.5% increase in gross profit year-over-year, a 49% decrease in general and administrative expenses, and a 43% reduction in operating expenses. IM Cannabis' shares rose 7.33% following the announcement.

Portfolio Pulse from Jelena Martinovic

March 28, 2024 | 3:19 pm

FCX

Financial analysts have observed a significant bullish trend in options trading for Freeport-McMoRan (NYSE:FCX), with 72% of trades being bullish. The analysis highlighted 18 unusual trades, with a focus on calls over puts, indicating a targeted price range of $38.0 to $55.0 for FCX. The volume and open interest trends for these options trades provide insights into liquidity and interest levels. Freeport-McMoRan, a major international mining company, has seen its stock price increase by 0.65% to $46.18, with indicators suggesting it may be overbought. The company's next earnings report is expected in 22 days.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 3:16 pm

DARE

Dare Bioscience (NASDAQ:DARE) reported Q4 earnings with losses of $(0.06) per share, surpassing the $(0.10) estimate, and sales of $1.81M, beating the $1.79M estimate. This represents a significant improvement over the previous year's losses of $(0.19) per share.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:15 pm

COCP

Cocrystal Pharma (NASDAQ:COCP) reported Q4 losses of $(0.44) per share, surpassing the analyst consensus estimate of $(0.60) by 26.67%. This represents an 18.52% improvement over the previous year's losses of $(0.54) per share.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:14 pm

CMCL

Caledonia Mining (AMEX:CMCL) reported a significant decrease in Q4 adjusted earnings per share to $0.02, down from $0.41 YoY, despite a 13.12% increase in sales to $38.66M from $34.18M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:13 pm